BridgeMD
Tests treatment safety and results for Knee Osteoarthristis
Official title Efficacy and Safety of Intra-articular Injections of Frozen Platelet-Rich Plasma in Patients With Knee Osteoarthritis
ClinicalTrials.gov ID: NCT07329361
What this study is testing
- What it's testing
- Evaluation of intra-articular injections in knee osteoarthritis using frozen-stored PRP. Compared with intra-articular injections of PRP applied at the time of collection.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Patients of both sexes.
- Aged between 40 and 85 years old.
- Diagnosed with osteoarthritis through clinical radiological examination.
- Joint pain equal to or less than 75 points on the KOOS (pain).
- Radiological severity grades 1, 2, and 3 according to the Ahlbäck scale.
You likely can't join if
- Body mass index \>35
- Diagnosed polyarticular disease.
- Previous arthroscopy in the last year.
- Severe mechanical deformity.
- Intra-articular hyaluronic acid injection in the last 12 months.
- Intra-articular corticosteroid or PRP injection in the last 6 months.
See the full eligibility criteria
- Patients of both sexes.
- Aged between 40 and 85 years old.
- Diagnosed with osteoarthritis through clinical radiological examination.
- Joint pain equal to or less than 75 points on the KOOS (pain).
- Radiological severity grades 1, 2, and 3 according to the Ahlbäck scale.
- Indication for intra-articular PRP infiltration.
- Body Mass Index values between 20 and 35.
- Negative serological tests for syphilis, HIV, HBV, and HCV.
- Possibility of observation during the follow-up period.
- Signature of informed consent.
- Body mass index \>35
- Diagnosed polyarticular disease.
- Previous arthroscopy in the last year.
- Severe mechanical deformity.
- Intra-articular hyaluronic acid injection in the last 12 months.
- Intra-articular corticosteroid or PRP injection in the last 6 months.
- Systemic autoimmune rheumatic disease (connective tissue diseases and systemic necrotizing vasculitis).
- Anemia or other hematological disorders.
- Positive serological tests for SYPHILIS, HIV, HBV, and HCV.
- Undergoing immunosuppressive treatments.
- Poorly controlled diabetes mellitus.
- Patients allergic to paracetamol.
- Pregnancy or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Vitoria-Gasteiz, Araba/Álava, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vitoria-Gasteiz, Araba/Álava, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.